Can Blood Flow Restriction Therapy Augment Rotator Cuff Strength?

Blood flow restriction (BFR) is an occlusion training program that utilizes a inflatable or mechanical tourniquet that limits blood flow in the arterial and venous system

Low-dose hydralazine during gestation reduces renal fibrosis in rodent offspring exposed to maternal high fat diet

BACKGROUND: Maternal high fat diet (HFD) promotes chronic kidney disease (CKD) in offspring. This is in accordance with the theory of fetal programming, which suggests adverse conditions occurring in utero predispose offspring to chronic conditions later in life. DNA methylation has been proposed as a key mechanism by which fetal programming occurs and is implicated in CKD progression. DNA demethylating drugs may interrupt the fetal programming of CKD by maternal obesity. Hydralazine, an antihypertensive agent, demethylates DNA at low doses which do not reduce blood pressure. We used a mouse model of maternal obesity to determine whether gestational administration of low-dose hydralazine to mothers can prevent CKD in offspring. METHODS: C57BL/6 dams received HFD or chow from 6 weeks prior to mating and were administered subcutaneous hydralazine (5mg/kg) or saline thrice weekly during gestation. Male offspring were weaned to chow and were sacrificed at either postnatal week 9 or week 32. Biometric and metabolic parameters, renal global DNA methylation, renal structural and functional changes and markers of fibrosis, oxidative stress and inflammation were measured in offspring at weeks 9 and 32. RESULTS: In week 9 offspring, maternal HFD consumption did not significantly alter anthropometric or metabolic parameters, or renal global DNA methylation. Week 32 offspring had increased renal global DNA methylation, together with albuminuria, glomerulosclerosis, renal fibrosis and oxidative stress. Administration of low-dose hydralazine to obese mothers during gestation reduced renal global DNA methylation and renal fibrotic markers in week 32 offspring. CONCLUSION: Gestational hydralazine reduced renal global DNA methylation in offspring of obese mothers and attenuated maternal obesity-induced renal fibrosis. These data support the use of low-dose hydralazine as a demethylating agent to prevent CKD arising in offspring due to maternal HFD consumption

Novel Role of Gestational Hydralazine in Limiting Maternal and Dietary Obesity-Related Chronic Kidney Disease

Background: Maternal obesity is a risk factor for chronic kidney disease (CKD) in offspring, underpinning the theory of the developmental origins of health and disease. DNA methylation has been implicated in the programming of adult chronic disease by maternal obesity, therefore, DNA demethylating agents may mitigate offspring risk of disease. In rodent models, low-dose hydralazine has previously been shown to reduce renal fibrosis via DNA demethylation. We used mouse models of maternal obesity and offspring obesity to determine whether administration of low-dose hydralazine during gestation can prevent fetal programming of CKD in offspring. Methods: Female C57BL/6 mice received high fat diet (HFD) or chow prior to mating, during gestation and lactation. During gestation, dams received subcutaneous hydralazine (5 mg/kg) or saline thrice-weekly. Male offspring weaned to HFD or chow, which continued until endpoint at 32 weeks. Biometric and metabolic parameters, renal global DNA methylation, renal functional and structural changes, and renal markers of fibrosis, inflammation and oxidative stress were assessed at endpoint. Results: Offspring exposed to maternal obesity or diet-induced obesity had significantly increased renal global DNA methylation, together with other adverse renal effects including albuminuria, glomerulosclerosis, renal fibrosis, and oxidative stress. Offspring exposed to gestational hydralazine had significantly reduced renal global DNA methylation. In obese offspring of obese mothers, gestational hydralazine significantly decreased albuminuria, glomerulosclerosis, and serum creatinine. Obese offspring of hydralazine-treated lean mothers displayed reduced markers of renal fibrosis and oxidative stress. Conclusion: Gestational hydralazine decreased renal global DNA methylation and exerted renoprotective effects in offspring. This supports a potential therapeutic effect of hydralazine in preventing maternal obesity or dietary obesity-related CKD, through an epigenetic mechanism

Web-based multimodal graphs for visually impaired people

This paper describes the development and evaluation of Web-based multimodal graphs designed for visually impaired and blind people. The information in the graphs is conveyed to visually impaired people through haptic and audio channels. The motivation of this work is to address problems faced by visually impaired people in accessing graphical information on the Internet, particularly the common types of graphs for data visualization. In our work, line graphs, bar charts and pie charts are accessible through a force feedback device, the Logitech WingMan Force Feedback Mouse. Pre-recorded sound files are used to represent graph contents to users. In order to test the usability of the developed Web graphs, an evaluation was conducted with bar charts as the experimental platform. The results showed that the participants could successfully use the haptic and audio features to extract information from the Web graphs

Low-dose hydralazine reduces albuminuria and glomerulosclerosis in a mouse model of obesity-related chronic kidney disease.

BACKGROUND: Obesity is a major risk factor for the development and progression of chronic kidney disease (CKD). DNA methylation has been implicated in the progression of CKD to end stage kidney disease. Drugs modifying DNA methylation, such as low-dose hydralazine, may reduce CKD progression. Using a mouse model of obesity, we aimed to determine whether low-dose hydralazine prevents obesity-related CKD. METHODS: From 8 weeks of age, male C57BL/6 mice received high fat diet (HFD) or chow, with or without low-dose hydralazine (25 mg/L) in drinking water for 24 weeks. Biometric and metabolic parameters, renal functional and structural changes, renal global DNA methylation, DNA methylation profile and markers of renal fibrosis, injury, inflammation and oxidative stress were assessed. RESULTS: HFD-fed mice developed obesity, with glucose intolerance, hyperinsulinaemia and dyslipidaemia. Obesity increased albuminuria and glomerulosclerosis, which were significantly ameliorated by low-dose hydralazine in the absence of a blood pressure-lowering effect. Obesity increased renal global DNA methylation and this was attenuated by low-dose hydralazine. HFD-induced changes in methylation of individual loci were also significantly reversed by low-dose hydralazine. Obese mice demonstrated increased markers of kidney fibrosis, inflammation and oxidative stress, but these markers were not significantly improved by hydralazine. CONCLUSION: Low-dose hydralazine ameliorated HFD-induced albuminuria and glomerulosclerosis, independent of alterations in biometric and metabolic parameters or blood pressure regulation. Although the precise mechanism of renoprotection in obesity is unclear, an epigenetic basis may be implicated. These data support repurposing hydralazine as a novel therapy to prevent CKD progression in obese patients. This article is protected by copyright. All rights reserved

Flow batteries for energy management : novel algebraic modelling approaches to properly assess their value

Redox Flow Battery (RFB) systems are promising technologies for the multi-hour electrical energy storage that will be necessary for on-demand electricity supply based on wind and solar power. Deriving maximum value from a RFB requires optimisation of both the system design and its operation. In this work three novel algebraic modelling approaches are introduced to represent RFB operation more accurately while maintaining quick optimisation times. First the typical linear programming (LP) optimisation problem is re-posed in terms of current-density rather than power, allowing voltaic losses to be expressed as a quadratic function (QP). Secondly, it is then shown that the current-density framework supports a novel constraint for the avoidance of high cell voltage that may damage the stack. Thirdly, for the first time a binary variable (MIQP) to describe active/idle states is introduced. This allows coulombic leakage and pumping losses to be modelled as fixed terms without constantly draining the RFB, and it allows for the optimisation of pump rating in a VRFB. In a day-ahead energy management case study, it is found that the QP optimisation predicts an additional 19 % annual revenue when compared to the LP optimisation. This capture of the true flexibility of the RFB operation allows its full value to be assessed, and therefore advances the case for their deployment within the energy system. Furthermore, the formulations developed are not only applicable to RFBs but to the scheduling of other battery systems, particularly Li-ion, and balance of plant optimisation, such as the sizing of inverters and climate control systems in the context of parasitic losses

DEVELOPING THE JUNGLEFY BREATHING WALL FOR ENHANCED INDOOR AIR QUALITY REMEDIATION

KEY RESEARCH HIGHLIGHTS Operational parameters of the Junglefy Breathing Wall system were determined and characterised. Data collected included system water loss, pressure drop, air distribution and the system’s effect on ambient temperature and relative humidity. Clean air delivery rates were calculated utilising the removal efficiencies. The system produced 25.86¬–28.70 m3/h per module, depending on particle size and airflow rate. A typical Breathing Wall of 10 m2, utilising 40 modules would thus produce up to 12,700 m3/h of particle-free air. Tests were conducted to identify the most appropriate plant species for survival in high pollution environments. All of the plant species tested, which are currently used in commercial applications of the Breathing Wall, recorded moderate air pollutant tolerance, and thus the system using the current plant species could possibly be used in industrial applications. Pollutant effect on air filled porosity of the substrate was negligible, even under extremely high pollutant loads. Air quality tests were conducted at the Lend Lease Head Office, and the efficiency of the first Breathing Wall installation was monitored. The Breathing Wall is successfully reducing ambient particulate matter and carbon dioxide relative to outdoors and other areas throughout the building. Additionally, air pollutants including carbon monoxide, volatile organic compounds and sulphur dioxide were below the detection limit of the equipment being used, indicating excellent indoor environmental quality. The results indicate that the Breathing Wall is working as intended

Measurement of air flow through a green-wall module

© 2006 Australasian Fluid Mechanics Society. All rights reserved. Green or living walls are active bio-filters developed to enhance air quality. Often, these walls form the base from which plants are grown; and the plant-wall system helps to remove both gaseous and particulate air pollutants. A green wall can be found indoors as well as outdoors, and could be assembled from modules in an arrangement similar to tiling. Measurement of air flow through such a module has been conducted in this work. The module is essentially a rectangular plastic box (dimensions about 500 mm x 500 mm x 130 mm) that holds a permeable bag containing a plant-growing medium (replacement for soil). The front face of the module has multiple openings for plants to protrude out from the bag inside. Plant roots are imbedded in the medium. A fan positioned at a central opening on the module‟s back face drives air through the medium-plant-roots mix and then onward through the plants‟ canopy; and these would help to remove both gaseous and particulate pollutants from the air. Drip-irrigation water is dispensed from a tube running along the open top-face of the module. The module has also a small drainage hole on its bottom face. Pressure drop across the module, air-flow distribution through it as well as flow rate have been obtained, in terms of variable parameters which include moisture content, growing-medium-plant-roots mix and plant type. The measurements help to determine the pattern of flow resistances which in turn will be used in a future CFD (Computational Fluid Dynamics) analysis for improving the design of the module, such that more appropriate flow distribution and flow rate would be achieved. All this is in addition to the better understanding of air flow through complex moist porous media

Hepatic breast cancer dissemination after an iatrogenic hepatic laceration during talc pleurodesis: a case report

<p>Abstract</p> <p>Background</p> <p>Talc pleurodesis is an effective treatment for malignant pleural effusion. We present a case of an asymptomatic hepatic laceration that occurred during pleurodesis in a breast cancer patient and led to hepatic tumor dissemination.</p> <p>Discussion</p> <p>Pleurodesis is a relatively safe procedure, although previous studies have described malignant invasion of scar tissue.</p> <p>Conclusion</p> <p>To our knowledge, this is the first case report of tumor spread due to a liver puncture during talc pleurodesis in a breast cancer patient.</p